The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Pacs Group Inc is $52.00, about 16.9% above its August 3 closing price of $44.50
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 16 three months ago
PACS•
